USDA Grants Amfora Exemption for Its Patented, Gene-Edited, Ultra-High Protein Soy, Accelerating Path to Market
The decision accelerates the path to commercialization for Amfora’s ultra-high protein soybeans.
- The decision accelerates the path to commercialization for Amfora’s ultra-high protein soybeans.
- The ruling opens the door for Amfora's gene-edited soybeans to provide a scalable, low-cost, high-density protein source.
- “This regulatory decision will accelerate our ability to scale the sustainable production of protein from soybeans," said Lloyd Kunimoto, CEO of Amfora.
- In addition to supporting Amfora’s development of ultra-high protein soy, the technology can be used to reverse decades of decline in protein content of commodity soybeans.